| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 6492 | 2018 |
| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 3676 | 2014 |
| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2941 | 2011 |
| The relation between inflammation and neurodegeneration in multiple sclerosis brains JM Frischer, S Bramow, A Dal-Bianco, CF Lucchinetti, H Rauschka, ... Brain 132 (5), 1175-1189, 2009 | 1720 | 2009 |
| The changing demographic pattern of multiple sclerosis epidemiology N Koch-Henriksen, PS Sørensen The Lancet Neurology 9 (5), 520-532, 2010 | 1582 | 2010 |
| Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study G Comi, M Filippi, F Barkhof, L Durelli, G Edan, O Fernández, HP Hartung, ... The Lancet 357 (9268), 1576-1582, 2001 | 1479 | 2001 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1323 | 2013 |
| A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis G Giovannoni, G Comi, S Cook, K Rammohan, P Rieckmann, ... New England Journal of Medicine 362 (5), 416-426, 2010 | 1132 | 2010 |
| Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ... Neurology 64 (7), 1144-1151, 2005 | 1055 | 2005 |
| Remyelination is extensive in a subset of multiple sclerosis patients P Patrikios, C Stadelmann, A Kutzelnigg, H Rauschka, M Schmidbauer, ... Brain 129 (12), 3165-3172, 2006 | 947 | 2006 |
| ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ... Multiple Sclerosis Journal 24 (2), 96-120, 2018 | 905 | 2018 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 838 | 2019 |
| EFNS guidelines on diagnosis and management of neuromyelitis optica J Sellner, M Boggild, M Clanet, RQ Hintzen, Z Illes, X Montalban, ... European journal of neurology 17 (8), 1019-1032, 2010 | 596 | 2010 |
| Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood A Koch, M Melbye, P Sørensen, P Homøe, HO Madsen, K Mølbak, ... Jama 285 (10), 1316-1321, 2001 | 573 | 2001 |
| The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ... Multiple Sclerosis Journal 21 (3), 305-317, 2015 | 568 | 2015 |
| Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study AM Josefsson, PKE Magnusson, N Ylitalo, P Sørensen, ... The Lancet 355 (9222), 2189-2193, 2000 | 537 | 2000 |
| Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study N Ylitalo, P Sørensen, AM Josefsson, PKE Magnusson, PK Andersen, ... the Lancet 355 (9222), 2194-2198, 2000 | 480 | 2000 |
| Stroke incidence and risk factors for stroke in Copenhagen, Denmark. G Boysen, J Nyboe, M Appleyard, PS Sørensen, J Boas, F Somnier, ... Stroke 19 (11), 1345-1353, 1988 | 462 | 1988 |
| Metastatic spinal cord compression: occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression F Bach, BH Larsen, K Rohde, SE Børgesen, F Gjerris, T Bøge-Rasmussen, ... Acta neurochirurgica 107, 37-43, 1990 | 461 | 1990 |
| Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis PS Sorensen, C Ross, KM Clemmesen, K Bendtzen, JL Frederiksen, ... The Lancet 362 (9391), 1184-1191, 2003 | 442 | 2003 |
